Stay updated with breaking news from Alhc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Alignment Healthcare (NASDAQ:ALHC – Free Report) had its price objective decreased by Morgan Stanley from $19.00 to $12.00 in a research note issued to investors on Wednesday, MarketBeat.com reports. Morgan Stanley currently has an overweight rating on the stock. A number of other brokerages have also commented on ALHC. UBS Group decreased their price objective […] ....
Rhenman & Partners Asset Management AB lifted its stake in Alignment Healthcare, Inc. (NASDAQ:ALHC – Free Report) by 207.7% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,000,000 shares of the company’s stock after acquiring an additional 675,000 shares during the […] ....
Alignment Healthcare, Inc. (NASDAQ:ALHC – Get Free Report) has been assigned an average rating of “Moderate Buy” from the nine analysts that are covering the firm, MarketBeat.com reports. Two research analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average twelve-month target price among […] ....
Alignment Healthcare (NASDAQ:ALHC – Get Free Report) is set to issue its quarterly earnings data after the market closes on Thursday, August 3rd. Analysts expect the company to announce earnings of ($0.20) per share for the quarter. Alignment Healthcare has set its Q2 2023 guidance at EPS and its FY 2023 guidance at EPS.Parties interested […] ....
Morgan Stanley reaffirmed their overweight rating on shares of Alignment Healthcare (NASDAQ:ALHC – Free Report) in a research report sent to investors on Friday, Benzinga reports. They currently have a $19.00 price target on the stock. Other research analysts also recently issued reports about the company. JPMorgan Chase & Co. reduced their price objective on […] ....